Sponsor Pipeline

AJU Pharm Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
1
Recruiting
2
Disease Areas
Active Trials by Phase
Phase 1
7
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT07643220 Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fasting… Moderate-to-severe Benign Prostatic Hyperplasia (BPH) Recruiting
NCT06933459 To Evaluate the Safety and Pharmacokinetic Characteristics of AJU-C714 and C714R in… Dyslipidemia Active, Not Recruiting
NCT07034781 A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and… Type2 Diabetes Mellitus Not Yet Recruiting
NCT07044765 A Study to Evaluate the Safety and Pharmacokinetics of Dapagliflozin, Linagliptin, and… Type2 Diabetes Mellitus Not Yet Recruiting
NCT07231861 Bioequivalence Study of AJU-R713 and R713R in Healthy Adult Volunteers Bronchial Asthma Not Yet Recruiting
NCT07581028 Bioequivalence Study of AJU-C715 and C715R in Healthy Adult Volunteers Hypercholerolemia Not Yet Recruiting
NCT07643233 Bioequivalence Study of AJU-G721 and G721R in Healthy Adult Volunteers Under Fed… Moderate-to-severe Benign Prostatic Hyperplasia (BPH) Not Yet Recruiting
Disease Areas
Get alerts when AJU Pharm Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free